Related references
Note: Only part of the references are listed.Injectable collagenase Clostridium histolyticum as a nonsurgical treatment for Dupuytren's disease
R. Arora et al.
OPERATIVE ORTHOPADIE UND TRAUMATOLOGIE (2016)
CTGF/CCN2 exerts profibrotic action in myoblasts via the up-regulation of sphingosine kinase-1/S1P3 signaling axis: Implications in the action mechanism of TGFβ
Gennaro Bruno et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat
Latha Satish et al.
BMC MUSCULOSKELETAL DISORDERS (2015)
Collagenase Clostridium Histolyticum versus Limited Fasciectomy for Dupuytren's Contracture: Outcomes from a Multicenter Propensity Score Matched Study
Chao Zhou et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2015)
Laminin-rich blood vessels display activated growth factor signaling and act as the proliferation centers in Dupuytren's contracture
Janeli Viil et al.
ARTHRITIS RESEARCH & THERAPY (2015)
CCN2 is required for recruitment of Sox2-expressing cells during cutaneous tissue repair
Matthew Tsang et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2015)
Autophagy fosters myofibroblast differentiation through MTORC2 activation and downstream upregulation of CTGF
Monique Bernard et al.
AUTOPHAGY (2014)
Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target
Liaquat S. Verjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture
Latha Satish et al.
BMC MEDICAL GENOMICS (2012)
DNA Copy Number Variations at Chromosome 7p14.1 and Chromosome 14q11.2 Are Associated with Dupuytren's Disease: Potential Role for MMP and Wnt Signaling Pathway
Barbara Shih et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2012)
Characterization of stem cells in Dupuytren's disease
S. Hindocha et al.
BRITISH JOURNAL OF SURGERY (2011)
Post-Transcriptional Regulation of α-Smooth Muscle Actin Determines the Contractile Phenotype of Dupuytren's Nodular Cells
Liaquat Suleman Verjee et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Dupuytren's Fibroblast Contractility by Sphingosine-1-Phosphate Is Mediated Through Non-Muscle Myosin II
Issei Komatsu et al.
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2010)
Injectable Collagenase Clostridium Histolyticum: A New Nonsurgical Treatment for Dupuytren's Disease
David Gilpin et al.
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2010)
Unique microRNA profile in Dupuytren's contracture supports deregulation of β-catenin pathway
Neda Mosakhani et al.
MODERN PATHOLOGY (2010)
The potential roles of cell migration and extra-cellular matrix interactions in Dupuytren's disease progression and recurrence
Linda Vi et al.
MEDICAL HYPOTHESES (2010)
Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease
Dietmar Ulrich et al.
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY (2009)
Platelet derived growth factor BB is a ligand for dermatan sulfate chain(s) of small matrix proteoglycans from normal and fibrosis affected fascia
Ewa M. Kozma et al.
BIOCHIMIE (2009)
Screening of potential prodrugs on cells derived from Dupuytren's disease patients
Sandra Kraljevic Pavelic et al.
BIOMEDICINE & PHARMACOTHERAPY (2009)
Type-1 Collagen differentially alters β-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells
Linda Vi et al.
BMC MUSCULOSKELETAL DISORDERS (2009)
Pacinian hypertrophy in a type 2A hand burn contracture and Pacinian hypertrophy and hyperplasia in a Dupuytren's contracture
Mehmet Oguz Yenidunya et al.
BURNS (2009)
β-Catenin Overexpression in Dupuytren's Disease Is Unrelated to Disease Recurrence
Ilse Degreef et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2009)
Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells
Linda Vi et al.
EXPERIMENTAL CELL RESEARCH (2009)
Transforming Growth Factor-β1 Stimulation Enhances Dupuytren's Fibroblast Contraction in Response to Uniaxial Mechanical Load Within a 3-Dimensional Collagen Gel
Marcus A. Bisson et al.
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2009)
THE ROLE OF AN MMP INHIBITOR IN THE REGULATION OF MECHANICAL TENSION BY DUPUYTREN'S DISEASE FIBROBLASTS
W. A. Townley et al.
JOURNAL OF HAND SURGERY-EUROPEAN VOLUME (2009)
An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease
Sandra Kraljevic Pavelic et al.
JOURNAL OF PATHOLOGY (2009)
Emerging roles of ADAM and ADAMTS metalloproteinases in cancer
N. Rocks et al.
BIOCHIMIE (2008)
Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren's Contracture
Latha Satish et al.
BMC MEDICAL GENOMICS (2008)
Matrix Metalloproteinase Inhibition Reduces Contraction by Dupuytren Fibroblasts
William A. Townley et al.
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2008)
Metalloproteinase gene expression correlates with clinical outcome in Dupuytren's disease
Phillip Johnston et al.
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2008)
GENE EXPRESSION ANALYSIS OF DUPUYTREN'S DISEASE: THE ROLE OF TGF-beta 2
A. Y. Zhang et al.
JOURNAL OF HAND SURGERY-EUROPEAN VOLUME (2008)
A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease
Phillip Johnston et al.
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2007)
beta-catenin signaling in fibroproliferative disease
Erin Bowley et al.
JOURNAL OF SURGICAL RESEARCH (2007)
Molecular profiling of ADAM12 in human bladder cancer
Camilla Frohlich et al.
CLINICAL CANCER RESEARCH (2006)
Gelatinase A activity in Dupuytren's disease
Katarzyna Augoff et al.
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2006)
Feedback inhibition of high TGF-β1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts
M. Wong et al.
JOURNAL OF HAND SURGERY-BRITISH AND EUROPEAN VOLUME (2006)
Dupuytren's contracture: An update of biomolecular aspects and therapeutic perspectives
A Cordova et al.
JOURNAL OF HAND SURGERY-BRITISH AND EUROPEAN VOLUME (2005)
A role for ADAM12 in breast tumor progression and stromal cell apoptosis
M Kveiborg et al.
CANCER RESEARCH (2005)
Wound healing-associated proteins Hsp47 and fibronectin are elevated in Dupuytren's contracture
JC Howard et al.
JOURNAL OF SURGICAL RESEARCH (2004)
The contractile properties and responses to tensional loading of Dupuytren's disease-derived fibroblasts are altered: A cause of the contracture?
MA Bisson et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2004)
Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture
A Qian et al.
UROLOGY (2004)
Hyperbaric oxygen for the treatment of early-phase Dupuytren's contracture
S Yildiz et al.
MICROSURGERY (2004)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease
D Ulrich et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2003)
The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord:: Expression of α-smooth muscle actin and the response, to stimulation by TGF-β1
MA Bisson et al.
JOURNAL OF HAND SURGERY-BRITISH AND EUROPEAN VOLUME (2003)
Elevated levels of β-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro -: art. no. 16
JC Howard et al.
BMC MUSCULOSKELETAL DISORDERS (2003)
Genetic susceptibility to Dupuytren's disease:: transforming growth factor beta receptor (TGFβR) gene polymorphisms and Dupuytren's disease
A Bayat et al.
BRITISH JOURNAL OF PLASTIC SURGERY (2003)
ADAM12 in human liver cancers:: TGF-β-regulated expression in stellate cells is associated with matrix remodeling
H Le Pabic et al.
HEPATOLOGY (2003)
Responsiveness of Dupuytren's disease fibroblasts to 5 alpha-dihydrotestosterone
A Pagnotta et al.
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2003)
Dupuytren's disease: Physiologic changes in nodule and cord fibroblasts through aging in vitro
KE Moyer et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2002)
Tamoxifen decreases fibroblast function and downregulates TGFβ2 in Dupuytren's affected palmar fascia
MA Kuhn et al.
JOURNAL OF SURGICAL RESEARCH (2002)
Genetic susceptibility in Dupuytren's disease:: Lack of association of a novel transforming growth factor β2 polymorphism in Dupuytren's disease
A Bayat et al.
JOURNAL OF HAND SURGERY-BRITISH AND EUROPEAN VOLUME (2002)
Androgen receptors in Dupuytren's contracture
A Pagnotta et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2002)
Genetic susceptibility in Dupuytren's disease - TGF-beta 1 polymorphisms and Dupuytren's disease
A Bayat et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2002)
Differences in α smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords
SA Dave et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2001)
Transforming growth factor-β1 promotes the morphological and functional differentiation of the myofibroblast
MB Vaughan et al.
EXPERIMENTAL CELL RESEARCH (2000)
Share Paper
